Healthcare

Elsight reported Q2 2026 revenue of approximately US$11.83 million, a roughly three-fold increase over the prior corresponding period and the highest quarterly revenue in the company's history. H1 2026 unaudited revenue totalled approximately US$23.4 million, 387% higher than H1 2025, already exceeding the company's …

FINEOS reported Total Revenue of €72.5 million for 1H26, up 7.9% from the prior corresponding period. On a constant currency basis, Total Revenue increased 7.2% to €72.0 million. Subscription revenue rose 15.0% to €41.9 million, representing 57.8% of total revenue, while Services revenue declined …

Life360 reported Total Q2'26 revenue of $159.0 million, a year-over-year increase of 38%, with total subscription revenue of $115.6 million, up 31%, and core subscription revenue of $111.1 million, up 34%. Advertising revenue reached $22.0 million, up 315% year-over-year, a record for the quarter …

• The outlook assumes constant-currency sales growth supported by higher volumes and pricing.

• The reading represents sector or derivative performance rather than the movement of any single company.

• The company is developing NNZ-2591 for rare neurodevelopmental disorders.

Hydrix Limited (ASX:HYD) has secured a three-year remote cardiac monitoring contract through its wholly owned Hydrix Medical subsidiary. The agreement with National Heart Centre Singapore carries an estimated value of approximately AUD 0.625mn, subject to the number of patients monitored, and is expected to …